Tissue Income Tax Expense vs Other Operating Expenses Analysis

TRX Stock   58.50  1.50  2.50%   
Tissue Regenix financial indicator trend analysis is much more than just breaking down Tissue Regenix Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tissue Regenix Group is a good investment. Please check the relationship between Tissue Regenix Income Tax Expense and its Other Operating Expenses accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tissue Regenix Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Income Tax Expense vs Other Operating Expenses

Income Tax Expense vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tissue Regenix Group Income Tax Expense account and Other Operating Expenses. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Tissue Regenix's Income Tax Expense and Other Operating Expenses is 0.4. Overlapping area represents the amount of variation of Income Tax Expense that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Tissue Regenix Group, assuming nothing else is changed. The correlation between historical values of Tissue Regenix's Income Tax Expense and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Tax Expense of Tissue Regenix Group are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Income Tax Expense i.e., Tissue Regenix's Income Tax Expense and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.4
Relationship DirectionPositive 
Relationship StrengthWeak

Income Tax Expense

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Tissue Regenix Group. It is also known as Tissue Regenix overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from Tissue Regenix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tissue Regenix Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tissue Regenix Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
As of January 7, 2025, Selling General Administrative is expected to decline to about 10.2 M. In addition to that, Tax Provision is expected to decline to about (14.5 K)

Tissue Regenix fundamental ratios Correlations

0.93-0.420.450.550.480.19-0.370.520.570.44-0.12-0.560.450.260.47-0.190.260.330.240.370.360.380.590.360.42
0.93-0.220.160.310.180.15-0.40.320.320.15-0.44-0.260.240.550.22-0.440.550.10.420.080.180.10.780.330.12
-0.42-0.22-0.7-0.79-0.790.520.03-0.32-0.62-0.81-0.450.77-0.230.29-0.6-0.340.29-0.110.14-0.84-0.9-0.88-0.060.3-0.73
0.450.16-0.70.870.960.150.050.480.830.960.7-0.930.65-0.560.80.47-0.560.63-0.380.940.720.92-0.160.10.97
0.550.31-0.790.870.94-0.09-0.080.650.940.90.63-0.930.56-0.50.880.36-0.50.6-0.080.870.760.88-0.110.240.86
0.480.18-0.790.960.94-0.02-0.080.570.890.990.73-0.950.57-0.580.880.51-0.580.57-0.390.970.790.96-0.170.110.98
0.190.150.520.15-0.09-0.02-0.080.160.07-0.05-0.05-0.060.440.05-0.01-0.10.050.52-0.03-0.09-0.43-0.210.060.520.07
-0.37-0.40.030.05-0.08-0.08-0.080.0-0.05-0.060.150.05-0.07-0.19-0.170.03-0.190.150.12-0.03-0.060.03-0.26-0.33-0.05
0.520.32-0.320.480.650.570.160.00.810.50.37-0.60.25-0.320.610.24-0.320.630.120.410.340.43-0.080.430.48
0.570.32-0.620.830.940.890.07-0.050.810.850.62-0.890.58-0.520.90.41-0.520.73-0.10.770.640.8-0.150.390.83
0.440.15-0.810.960.90.99-0.05-0.060.50.850.72-0.940.56-0.570.850.53-0.570.51-0.440.980.820.98-0.170.030.99
-0.12-0.44-0.450.70.630.73-0.050.150.370.620.72-0.670.49-0.980.750.73-0.980.59-0.520.710.50.71-0.80.170.74
-0.56-0.260.77-0.93-0.93-0.95-0.060.05-0.6-0.89-0.94-0.67-0.650.53-0.85-0.50.53-0.630.24-0.91-0.74-0.90.13-0.17-0.93
0.450.24-0.230.650.560.570.44-0.070.250.580.560.49-0.65-0.440.650.28-0.440.77-0.130.50.20.48-0.210.520.63
0.260.550.29-0.56-0.5-0.580.05-0.19-0.32-0.52-0.57-0.980.53-0.44-0.67-0.721.0-0.580.47-0.55-0.36-0.550.9-0.22-0.59
0.470.22-0.60.80.880.88-0.01-0.170.610.90.850.75-0.850.65-0.670.47-0.670.67-0.280.760.640.79-0.340.480.83
-0.19-0.44-0.340.470.360.51-0.10.030.240.410.530.73-0.50.28-0.720.47-0.720.35-0.540.520.450.52-0.6-0.030.53
0.260.550.29-0.56-0.5-0.580.05-0.19-0.32-0.52-0.57-0.980.53-0.441.0-0.67-0.72-0.580.47-0.55-0.36-0.550.9-0.22-0.59
0.330.1-0.110.630.60.570.520.150.630.730.510.59-0.630.77-0.580.670.35-0.58-0.010.440.070.4-0.370.640.56
0.240.420.14-0.38-0.08-0.39-0.030.120.12-0.1-0.44-0.520.24-0.130.47-0.28-0.540.47-0.01-0.46-0.25-0.420.390.24-0.48
0.370.08-0.840.940.870.97-0.09-0.030.410.770.980.71-0.910.5-0.550.760.52-0.550.44-0.460.810.98-0.16-0.110.96
0.360.18-0.90.720.760.79-0.43-0.060.340.640.820.5-0.740.2-0.360.640.45-0.360.07-0.250.810.87-0.02-0.220.75
0.380.1-0.880.920.880.96-0.210.030.430.80.980.71-0.90.48-0.550.790.52-0.550.4-0.420.980.87-0.17-0.110.96
0.590.78-0.06-0.16-0.11-0.170.06-0.26-0.08-0.15-0.17-0.80.13-0.210.9-0.34-0.60.9-0.370.39-0.16-0.02-0.17-0.19-0.2
0.360.330.30.10.240.110.52-0.330.430.390.030.17-0.170.52-0.220.48-0.03-0.220.640.24-0.11-0.22-0.11-0.190.07
0.420.12-0.730.970.860.980.07-0.050.480.830.990.74-0.930.63-0.590.830.53-0.590.56-0.480.960.750.96-0.20.07
Click cells to compare fundamentals

Tissue Regenix Account Relationship Matchups

Tissue Regenix fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets36.7M34.1M38.3M43.2M49.7M30.2M
Total Stockholder Equity28.5M25.4M26.0M30.2M34.7M25.9M
Liabilities And Stockholders Equity36.7M34.1M38.3M43.2M49.7M30.3M
Other Stockholder Equity93.5M98.1M138.9M154.4M177.5M186.4M
Total Liab8.9M9.5M13.0M13.9M16.0M16.8M
Common Stock11.7M11.8M13.3M91K104.7K99.4K
Common Stock Shares Outstanding44.5M70.3M70.3M70.4M81.0M80.5M
Other Current Liab1.4M477.5K4.4M2.6M3.0M1.6M
Total Current Liabilities3.3M3.2M5.5M4.7M5.4M5.7M
Property Plant And Equipment Net5.7M6.7M7.4M9.0M10.4M10.9M
Net Debt(4.2M)175.7K3.0M4.7M5.5M5.7M
Retained Earnings(77.7M)(84.7M)(96.8M)(123.8M)(111.4M)(105.8M)
Accounts Payable1.3M2.6M1.1M1.2M1.4M921.0K
Cash9.6M5.7M4.9M4.7M4.2M4.0M
Non Current Assets Total16.6M17.8M20.0M24.2M27.8M29.2M
Non Currrent Assets Other(8.6M)(8.6M)(9.6M)(5.2M)(6.0M)(6.3M)
Cash And Short Term Investments9.6M5.7M4.9M4.7M4.2M4.0M
Net Receivables3.5M3.4M4.3M2.4M2.7M2.1M
Good Will8.6M8.6M9.6M11.6M10.4M9.1M
Non Current Liabilities Total5.6M6.3M7.5M9.2M10.5M11.1M
Other Current Assets1.7M1.2M834.7K4.1M4.7M4.9M
Property Plant And Equipment Gross5.7M9.1M8.9M14.4M16.6M17.4M
Total Current Assets20.1M16.3M18.3M19.1M22.0M20.8M
Accumulated Other Comprehensive Income955K197.9K(942.7K)(529.5K)(608.9K)(639.4K)
Intangible Assets10.9M11.1M12.5M3.5M4.1M3.9M
Property Plant Equipment2.4M5.7M9.1M8.9M10.3M10.8M
Net Tangible Assets7.2M17.7M19.3M17.6M20.2M17.7M
Inventory7.1M7.2M9.0M10.4M11.9M12.5M
Other Liab670K560K640K520K468K618.7K
Net Invested Capital31.3M38.8M37.5M36.1M41.6M38.4M
Net Working Capital16.8M17.7M15.4M14.4M16.5M15.8M
Capital Stock9.6M9.2M9.2M91K81.9K77.8K
Short Long Term Debt Total5.3M5.9M8.0M9.4M10.8M6.8M
Long Term Debt2.8M4.5M5.3M5.5M6.4M4.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Tissue Stock

Balance Sheet is a snapshot of the financial position of Tissue Regenix Group at a specified time, usually calculated after every quarter, six months, or one year. Tissue Regenix Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Tissue Regenix and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Tissue currently owns. An asset can also be divided into two categories, current and non-current.